ScholarIQanswers from OpenAlex

Rapamycin has dual opposing effects on proteinuric experimental nephropathies: is it a matter of podocyte damage?

PaperCitations, authors & open-access status

Rapamycin has dual opposing effects on proteinuric experimental nephropathies: is it a matter of podocyte damage? is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Rapamycin has dual opposing effects on proteinuric experimental nephropathies: is it a matter of podocyte damage? have?

ScholarIQcitation count

Rapamycin has dual opposing effects on proteinuric experimental nephropathies: is it a matter of podocyte damage? has 63 citations in the OpenAlex counts ScholarIQ stores.

When was Rapamycin has dual opposing effects on proteinuric experimental nephropathies: is it a matter of podocyte damage? published?

ScholarIQyear

Rapamycin has dual opposing effects on proteinuric experimental nephropathies: is it a matter of podocyte damage? has 2009 year in the ScholarIQ index.

What is the open-access status of Rapamycin has dual opposing effects on proteinuric experimental nephropathies: is it a matter of podocyte damage??

ScholarIQoa status

Rapamycin has dual opposing effects on proteinuric experimental nephropathies: is it a matter of podocyte damage? has closed oa status in the ScholarIQ index.

What is the DOI of Rapamycin has dual opposing effects on proteinuric experimental nephropathies: is it a matter of podocyte damage??

ScholarIQdoi

The DOI for Rapamycin has dual opposing effects on proteinuric experimental nephropathies: is it a matter of podocyte damage? is on the source record.

What is the PMID of Rapamycin has dual opposing effects on proteinuric experimental nephropathies: is it a matter of podocyte damage??

ScholarIQpmid

The PMID for Rapamycin has dual opposing effects on proteinuric experimental nephropathies: is it a matter of podocyte damage? is on the source record.

What is the OpenAlex record for Rapamycin has dual opposing effects on proteinuric experimental nephropathies: is it a matter of podocyte damage??

ScholarIQopenalex

The OpenAlex for Rapamycin has dual opposing effects on proteinuric experimental nephropathies: is it a matter of podocyte damage? is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial